Cantel Medical entered into a definitive agreement with North American Science Associates to acquire its Sterility Assurance Monitoring Products division.
Here are four points:
1. Cantel Medical will pay $13.5 million in cash consideration.
2. NAMSA's Sterility Assurance Monitoring Products manufactures biological and chemical indicators which are used to monitor the effectiveness of sterilization processes.
3. NAMSA's sterility assurance products will be integrated into the Crosstex product portfolio and reported in Cantel Medical's healthcare disposables segment.
4. The transaction is expected to close in the third quarter of fiscal year 2016.